TEVJF OTC Stock Today

TEVJF -  USA Stock  

USD 9.76  0.00  0.00%

TEVA PHARMACEUTICAL is trading at 9.76 as of the 22nd of October 2021, a No Change since the beginning of the trading day. The stock's lowest day price was 9.76. TEVA PHARMACEUTICAL has 50 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for TEVA PHARMACEUTICAL INDUSTRIES are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of July 2021 and ending today, the 22nd of October 2021. Click here to learn more.
 Market Performance
1 of 100
  Odds Of Distress
Less than 50
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. The company has 1.1 B outstanding shares. More on TEVA PHARMACEUTICAL INDUSTRIES
Follow Valuation Daily Balance Of Power
Check how we calculate scores

TEVA PHARMACEUTICAL OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. TEVA PHARMACEUTICAL's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding TEVA PHARMACEUTICAL or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
TEVA PHARMACEUTICAL has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 16.32 B. Net Loss for the year was (3.92 B) with profit before overhead, payroll, taxes, and interest of 7.73 B.
Latest headline from www.equities.com: Antares Pharma gains 1.67 percent in Light Trading on October 20 - Equities.com
Legal NameTEVA PHARMACEUTICAL INDUSTRIES
CEOCarlo Notaristefani  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of TEVA PHARMACEUTICAL's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyFairly Valued
TEVA PHARMACEUTICAL INDUSTRIES [TEVJF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Large-Cap' category with current market capitalization of 10.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TEVA PHARMACEUTICAL's market, we take the total number of its shares issued and multiply it by TEVA PHARMACEUTICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. TEVA PHARMACEUTICAL classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 1.1 B outstanding shares. TEVA PHARMACEUTICAL INDUSTRIES has accumulated about 2.44 B in cash with 451 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21.
Check TEVA PHARMACEUTICAL Probability Of Bankruptcy
Ownership
TEVA PHARMACEUTICAL maintains a total of 1.1 Billion outstanding shares. About 96.0 % of TEVA PHARMACEUTICAL outstanding shares are held by regular investors with 0.64 (%) owned by insiders and only 3.76 % by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check TEVJF Ownership Details

TEVJF Stock Price Odds Analysis

What are TEVA PHARMACEUTICAL's target price odds to finish over the current price? Based on a normal probability distribution, the odds of TEVA PHARMACEUTICAL jumping above the current price in 90 days from now is about 23.85%. The TEVA PHARMACEUTICAL INDUSTRIES probability density function shows the probability of TEVA PHARMACEUTICAL otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon TEVA PHARMACEUTICAL has a beta of 0.4559. This usually implies as returns on the market go up, TEVA PHARMACEUTICAL average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding TEVA PHARMACEUTICAL INDUSTRIES will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2201, implying that it can generate a 0.22 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 9.76HorizonTargetOdds Up 9.76 
75.95%90 days
 9.76 
23.85%
Based on a normal probability distribution, the odds of TEVA PHARMACEUTICAL to move above the current price in 90 days from now is about 23.85 (This TEVA PHARMACEUTICAL INDUSTRIES probability density function shows the probability of TEVJF OTC Stock to fall within a particular range of prices over 90 days) .

TEVA PHARMACEUTICAL Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. TEVA PHARMACEUTICAL market risk premium is the additional return an investor will receive from holding TEVA PHARMACEUTICAL long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in TEVA PHARMACEUTICAL. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although TEVA PHARMACEUTICAL's alpha and beta are two of the key measurements used to evaluate TEVA PHARMACEUTICAL's performance over the market, the standard measures of volatility play an important role as well.

TEVJF Stock Against Markets

Picking the right benchmark for TEVA PHARMACEUTICAL otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in TEVA PHARMACEUTICAL otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for TEVA PHARMACEUTICAL is critical whether you are bullish or bearish towards TEVA PHARMACEUTICAL INDUSTRIES at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in TEVA PHARMACEUTICAL without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

TEVA PHARMACEUTICAL Corporate Directors

TEVA PHARMACEUTICAL corporate directors refer to members of a TEVA PHARMACEUTICAL board of directors. The board of directors generally takes responsibility for the TEVA PHARMACEUTICAL's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of TEVA PHARMACEUTICAL's board members must vote for the resolution. The TEVA PHARMACEUTICAL board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Nechemia Peres - Independent DirectorProfile
Moshe Many - Independent DirectorProfile
Roger Abravanel - Independent DirectorProfile
Richard Lerner - Independent DirectorProfile
Additionally, take a look at World Market Map. Note that the TEVA PHARMACEUTICAL information on this page should be used as a complementary analysis to other TEVA PHARMACEUTICAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for TEVJF OTC Stock analysis

When running TEVA PHARMACEUTICAL price analysis, check to measure TEVA PHARMACEUTICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TEVA PHARMACEUTICAL is operating at the current time. Most of TEVA PHARMACEUTICAL's value examination focuses on studying past and present price action to predict the probability of TEVA PHARMACEUTICAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move TEVA PHARMACEUTICAL's price. Additionally, you may evaluate how the addition of TEVA PHARMACEUTICAL to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
The market value of TEVA PHARMACEUTICAL is measured differently than its book value, which is the value of TEVJF that is recorded on the company's balance sheet. Investors also form their own opinion of TEVA PHARMACEUTICAL's value that differs from its market value or its book value, called intrinsic value, which is TEVA PHARMACEUTICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TEVA PHARMACEUTICAL's market value can be influenced by many factors that don't directly affect TEVA PHARMACEUTICAL underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TEVA PHARMACEUTICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine TEVA PHARMACEUTICAL value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TEVA PHARMACEUTICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.